Mitochondria‐Targeted Triphenylphosphonium Conjugated C‐3 Modified Betulin: Synthesis, Antitumor Properties and Mechanism of Action

Authors:

Abstract
A series of mitochondria‐targeted triphenylphosphonium conjugated C‐3 modified betulin were synthesized and evaluated against tumor cells. As a result, a new derivative 13 i, the conjugate of 3‐O‐(3′‐acetylphenylacetate)‐betulin with triphenylphosphonium, was identified as the one with the best anti‐tumor effect. Conjugate 13 i significantly inhibited HCT116 cells with IC50 at 0.66 μM. While betulin, C‐3 modified betulin, and the triphenylphosphonium moiety showed no inhibition of HCT116 cell proliferation at 20 μM. More importantly, 13 i exhibited a more cytotoxic effect against the tumor cell HCT116 than normal cell NCM460. Mode of action studies demonstrated that 13 i induced the G2/M phase cell cycle arrest and apoptosis in HCT116 cells through the mitochondrial pathway. Structure‐activity relationship analysis revealed that integration of triphenylphosphonium moiety into the C‐28 of betulin can greatly improve cytotoxicity. Appropriate modification on C‐3 of the conjugate would improve the selectivity.
Funding Information
  • National Natural Science Foundation of China (22177020)

This publication has 25 references indexed in Scilit: